Therapeutic applications of CRISPR/Cas9 system in gene therapy

被引:0
作者
Hasan Mollanoori
Shahram Teimourian
机构
[1] Iran University of Medical Sciences (IUMS),Department of Medical Genetics
[2] Tehran University of Medical Sciences,Department of Infectious Diseases, School of Medicine, Pediatric Infectious Diseases Research Center
来源
Biotechnology Letters | 2018年 / 40卷
关键词
CRISPR/cas9; Gene therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Gene therapy is based on the principle of the genetic manipulation of DNA or RNA for treating and preventing human diseases. The clustered regularly interspaced short palindromic repeats/CRISPR associated nuclease9 (CRISPR/Cas9) system, derived from the acquired immune system in bacteria and archaea, has provided a new tool for accurate manipulation of genomic sequence to attain a therapeutic result. The advantage of CRISPR which made it an easy and flexible tool for diverse genome editing purposes is that a single protein (Cas9) complex with 2 short RNA sequences, function as a site-specific endonuclease. Recently, application of CRISPR/Cas9 system has become popular for therapeutic aims such as gene therapy. In this article, we review the fundamental mechanisms of CRISPR-Cas9 function and summarize preclinical CRISPR-mediated gene therapy reports on a wide variety of disorders.
引用
收藏
页码:907 / 914
页数:7
相关论文
共 365 条
[1]  
Canver MC(2015)BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis Nature 527 192-197
[2]  
Smith EC(2015)Modeling human severe combined immunodeficiency and correction by CRISPR/Cas9-enhanced gene targeting Cell Rep 12 1668-1677
[3]  
Sher F(2016)CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo Sci Rep 6 22312-222
[4]  
Pinello L(2017)CRISPR/Cas9: transcending the reality of genome editing Mol Ther Nucl Acids 7 211-389
[5]  
Sanjana NE(2017)CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease Sci Transl Med 9 eaah3480-929
[6]  
Shalem O(2016)CRISPR/Cas9 beta-globin gene targeting in human haematopoietic stem cells Nature 539 384-89
[7]  
Chen DD(2017)In vivo genome editing restores dystrophin expression and cardiac function in Dystrophic mice Circ Res 121 923-1390
[8]  
Schupp PG(2014)Gene regulation by engineered CRISPR-Cas systems Curr Opin Microbiol 18 83-216
[9]  
Vinjamur DS(2015)Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs Cell Rep 12 1385-2584
[10]  
Garcia SP(2017)What rheumatologists need to know about CRISPR/Cas9 Nat Rev Rheumatol 13 205-154